Seminal 5′tRF-Glu-CTC as a Biomarker for Oligozoospermia and ART Outcome Prediction

These results suggest that 5'tRF-Glu-CTC might be serve as a potential biomarker and could play a role in the pathophysiology of oligozoospermia.

Authors

Institutions

Publication Details

Journal
Basic and Clinical Andrology
Published
2025-09-01
DOI
https://doi.org/10.1186/s12610-025-00283-0
Citations
2
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
1.61

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Seminal 5′tRF-Glu-CTC as a Biomarker for Oligozoospermia and ART Outcome Prediction

Sezgin Güneş, Bülent Ayas, Neslihan Hekim, Elzem Nisa Alkan
2 citations
Basic and Clinical Andrology
RNA modifications and cancer
1.61
article

Seminal 5′tRF-Glu-CTC as a Biomarker for Oligozoospermia and ART Outcome Prediction

Sezgin Güneş, Bülent Ayas, Neslihan Hekim, Elzem Nisa Alkan
article en
2 citations

Abstract

These results suggest that 5'tRF-Glu-CTC might be serve as a potential biomarker and could play a role in the pathophysiology of oligozoospermia.

Basic and Clinical AndrologyVol. 35(1)
Ondokuz Mayıs University (TR)
Ondokuz Mayis Üniversitesi
Openalex Percentile: Top 15%
RNA modifications and cancer
1.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.